Fig. 1 · Structure

Documents & Downloads

Donepezil

Cat. No. A13079 CAS 120014-06-4

AChE inhibitor

Donepezil is a noncompetitive acetylcholineesterase inhibitor, which can readily cross the blood brain barrier and increase the concentration of cortical acetylcholine. It is known that Donepezil is a useful tool in the study of Alzheimer's disease.

In Stock

Free Aliquoting for Your Order

Tell us your preferred amount per vial. We’ll confirm the options.

Biological Activity

Cellular Effect

Cell Line Activity Value Description Reference
BV-2 IC50 1.54 μM Cytotoxicity against mouse BV-2 cells assessed as reduction in cell viability measured after 24 hrs by MTT assay [PMID: 34923430]
CHO IC50 34.3 μM Inhibition of Cav1.2 current measured using QPatch automatic path clamp system in CHO cells expressing Cav1.2, beta-2 and alpha-2/delta-1 subunits [PMID: 23812503]
HEK293 IC50 > 200 μM Cytotoxicity against human HEK293 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay [PMID: 32388114]
HEK293 IC50 0.009 μM Inhibition of human recombinant AChE expressed in HEK293 cells using acetylthiocholine iodide as substrate preincubated for 30 mins followed by substrate addition measured after 30 mins by Ellman's method [PMID: 26471320]
HEK293 IC50 0.01 μM Inhibition of recombinant human AChE expressed in HEK293 cells using acetylthiocholine iodide as substrate pretreated for 5 mins followed by substrate addition measured for 5 mins by UV-Vis spectrophotometric method [PMID: 28242552]
HEK293 IC50 0.016 μM Inhibition of recombinant human AChE expressed in HEK293 cells preincubated for 15 mins [PMID: 25418133]
HEK293 IC50 6.2 nM Inhibition of human recombinant AChE expressed in HEK293 cells using acetylthiocholine iodide as substrate by Ellman's method [PMID: 31304000]
HEK293 IC50 7.5 μM Inhibition of human recombinant BuChE expressed in HEK293 cells using S-butyrylthiocholine iodide as substrate preincubated for 30 mins followed by substrate addition measured after 30 mins by Ellman's method [PMID: 26471320]
HEK293 IC50 8.2 μM Inhibition of recombinant human BuChE expressed in HEK293 cells preincubated for 15 mins [PMID: 25418133]
HepG2 IC50 262727 nM Cytotoxicity against human HepG2 cells assessed as reduction in cell viability incubated for 24 hrs by MTT assay [PMID: 34530383]
HFF IC50 0.091 μM Cytotoxicity against HFF cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay [PMID: 32088494]
HT-22 IC50 56.42 μM Cytotoxicity against mouse HT-22 cells assessed as reduction in cell viability measured after 24 hrs by MTT assay [PMID: 34923430]
MCF7 IC50 0.06 μM Cytotoxicity against human MCF7 cells after 48 hrs by MTT assay [PMID: 32088494]
NIH3T3 IC50 316.42 μM Cytotoxicity against mouse NIH/3T3 cells after 24 hrs by MTT assay [PMID: 27789142]
SH-SY5Y IC50 > 200 μM Cytotoxicity against human SH-SY5Y cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay [PMID: 32388114]
SH-SY5Y IC50 0.3 μM Cytotoxicity against human SH-SY5Y cells measured after 48 hrs by MTT assay [PMID: 32088494]
SH-SY5Y IC50 15.54 μM Cytotoxicity against human SH-SY5Y cells after 72 hrs by SRB assay [PMID: 27823887]
SH-SY5Y IC50 155 μM Antialzheimer activity in human SH-SY5Y cells assessed as inhibition of GA-induced tau hyperphosphorylation at Ser396 residue incubated for 24 hrs by ELISA [PMID: 36257284]
SH-SY5Y IC50 202 μM Antioxidant activity against okadaic acid-induced ROS generation in human SH-SY5Y cells assessed as reduction in DCF fluorescence intensity pretreated for 24 hrs followed by okadaic acid addition for 24 hrs by DCFH-DA dye based fluorescence analysis [PMID: 36257284]

19 records · Scroll to view more

Specifications

Manufacturer Adooq Bioscience
Actions Inhibitor
CAS Number 120014-06-4
Applications AChE inhibitor
Formula C24H29NO3
Molecular Weight 379.5
SMILES
COC1=C(C=C2C(=C1)CC(C2=O)CC3CCN(CC3)CC4=CC=CC=C4)OC

Storage & Solubility

In Vitro Solubility

Reported Solubility

SolventReported Solubility
DMSO 68 mg/mL (179.18 mM)
Ethanol <1 mg/mL

Preparing Stock Solutions

Stock preparation is unavailable for this product molecular weight.

Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.

Storage

Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.

Added to your cart

View Cart Checkout
Loading...